15 November 2016 - The US' largest physician organisation is supporting value-based pricing for medications.

The American Medical Association Tuesday announced it supports initiatives “aimed at changing the fundamentals of prescription drug pricing without compromising patient outcomes and access.” Its new policy was adopted at the AMA's interim meeting in Orlando, Florida., over the weekend.

The AMA says it “seeks to blunt growing pharmaceutical spending rates” by incorporating a balance of benefits and cost when pricing drugs. The organisation believes prices should be set by objective, independent agencies that use evidence and data. Processes to set those prices should be transparent, not burden physicians or patients and maintain affordability for patients, according to the AMA.

Read Modern Healthcare article